Kinetics of high-energy phosphates in allopurinol-pretreated ischaemic and post-lschaemic skeletal muscle: An in vivo magnetic resonance spectroscopy study

European Surgical Research

Volumn 29, Issue 2, 1997, Pages 101-106

  Gurke L ^a   Erhard, P ^b   Marx, A ^c   Harder, F ^a   Seelig, J ^b   Heberer, M ^a  

^a Departments of Surgical Research   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Ospedale Civico Lugano   (Switzerland)

Author keywords

AUopurinol; High energy phosphates; Ischaemia; MR spectroscopy; Reperfusion; Skeletal muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALLOPURINOL; CREATINE PHOSPHATE; PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ISCHEMIA; KINETICS; MALE; MUSCLE BLOOD FLOW; MUSCLE FUNCTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; REPERFUSION; SKELETAL MUSCLE;

ADENOSINE TRIPHOSPHATE; ALLOPURINOL; ANIMALS; ISCHEMIA; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCLE, SKELETAL; PHOSPHOCREATINE; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 0031057978     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000129513     Document Type: Article

References (24)

1. Pcrlcr BA. Tohmeh AG. Bulklcy GB: Inhibition of ihc compartment syndrome by the ablation of free radical-mediated reperfusion injury. Surgery 1990:108:40-47.
2. Smith JK. Carden DL. Korthuis RJ: Role of xanthine oxidase in post-ischemic microvascular injury' in skeletal muscle. Am J Physiol 1989: 257:H1782-H1789.
3. Korthuis RJ, Granger DN, Towns-ley MI, Taylor AH: The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ Res 1985:57:599-609.
4. Oredsson S. Plate G. Qvarfordt P: Allopurinol - a free radical scavenger - reduces reperfusion injury in skeletal muscle. Hur J Vase Surg 199l;5:64.
5. McCutchan HJ. Schwappach JR. Enquist EG. Walden DL. Terada LS. Reiss OK. et al: Xanthine oxidase-derived H?0; contributes to reperfusion injury of ischemic skeletal muscle. Am J Physiol 1990:258: H1415-H1419.
6. Ofarrell D. Chen LE. Seaber AV. Murrell GAC. Urbaniak JR: Efficacy of recombinant human manganese superoxidc dismutase compared to allopurinol in protection of ischemic skeletal muscle against ‘no-rcflow'. J Reconstr Microsurg 1995; 11:207-214.
7. Marx A, Giirke L, Sutter PM, Erhard P, Landmann J, Harder F, et al: Allopurinol improves postisch-emic muscle function but not high-energy phosphate levels. Ann NY Acad'Sci 1994:723:412-414.
8. DeWall RA, Vasko KA, Stanley EL, Kczdi P: Response of the ischemic myocardium to allopurinol. Am Heart J 1971:82:367.
9. Idstrom J. Soussi B. Elandcr A. By-lund-Fellenius AC: Purine metabolism after in vivo ischemia and re-perlusion in rat skeletal muscle. Am J Physio! 1990;258:H1668-H1673.
10. Karwinski W, Drange A, Farstad M, Ulvik R, Sorcidc O: 60 min normo-thermie liver ischemia in rats: Allopurinol improves energy status and bile flow during rcperfusion. Eur Surg Res 1990:22:27-33.
11. Lasley RD, Ely SW, Berne RM, Mentzer RM Jr.: Allopurinol enhanced adenine nucleotide repletion after myocardial ischemia in the isolated rat heart. J Clin Invest 1988; 81:16-20.
12. Garcia Garcia J. Martin Rcllan C. Refoyo Enrinqucz MA. Madruga M. Marino Hernandez E. Macias Nunez JF. et al: Improved survival in intestinal ischemia by allopurinol not related to xanthine-oxidase inhibition. J Surg Res 1990:48:144-146.
13. Marx A, Sutter PM, Giirke L, Erhard P, Hebercr M, Landmann J. et al: Moderate hypothermia during tourniquet ischemia improves post-ischemic muscle function and correlates with high energy phosphate levels. Surg Forum 1992:43:569-571.
14. Taylor DJ, Bore PJ, Styles P, Ga-dian DG, Radda GK: Bioenergetics of intact human muscle. A JIP nuclear magnetic resonance study. Mol Biol Med 1983:1:77-94.
15. Meyer RA, Kushmcrick MJ, Brown TR: Application of 3IP NMR spectroscopy to the study of striated muscle metabolism. Am J Physiol 1982;242:C1-C11.
16. Sapega AA. Hcppcnstall RB. Chance B. Park YS. Sokolow D: Optimizing tourniquet application and release times in extremity surgery. J Bone Joint Surg Am 1985:67:303-314.
17. Newman RJ: Metabolic effects of tourniquet ischaemia studied by nuclear magnetic resonance spectroscopy. J Bone Joint Surg Br 1984:66-15:434-440.
18. Soussi B, Idstrom J, Bylund-Fcllc-nius AC, Schersten T: Dynamics of skeletal muscle energetics during ischemia and reperfusion assessed by in vivo 11P NMR. NMR Biomcd 1990:3:71-77.
19. Godin DV: Allopurinol and iscli-emia/reperfusion injury: New use for an old drug? Can J Cardiol 1991: 7(4): 163-169.
20. Saez JC, Cifuentes F, Ward PH, Gunther B, Vivaldi E: Tourniquet shock in rats: Effects of allopurinol on biochemical changes of the gastrocnemius muscle subjected to ischemia followed by reperfusion. Biochem Med Mctab Biol 1986:35: 199-209.
21. Punch J. Rees R. Cashmer B. Wilkins E. Smith DJ. Till GO: Xanthine oxidase: Its role in the no-reflow phenomenon. Sutgerv 1992:111: 169-176.
22. Zager RA. Gmur DJ: Effects of xanthine oxidase inhibition on ischemic acute renal failure in the rat. Am J Physiol 1989;257:F953-F958.
23. Zimmerman BI, Parks DA, Grisham MB, Granger DN: Allopurinol does not enhance the antioxidant properties of extracellular fluid. Am J Physiol 1988:255:11202-11206.
24. Moorhousc PC. Grootveld M. Halli-wcll B. Quinlan JG. Gutteridge JM: Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett 1987:213:23-28.